InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.

Yosemite is a San Francisco-based venture capital firm focused on oncology, aiming to make cancer non-lethal within our lifetime. The firm combines for-profit investing with philanthropic grants to support early cancer research and finance innovative therapies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Yosemite is an oncology-focused venture capital firm based in San Francisco, California. Founded in 2023, it aims to make cancer non-lethal within our lifetime by combining for-profit investments with philanthropic grantmaking. The firm supports early-stage academic research and invests in companies that translate oncology science into effective therapies and diagnostics. With a commitment to improving patient experiences and care delivery, Yosemite has deployed over $18 million in grants and raised more than $200 million for its second fund, targeting a total of $350 million.
Yosemite focuses on early-stage investments in oncology, including seed and Series A funding for companies developing cancer therapeutics, diagnostics, and AI-enabled cancer care solutions. The firm also provides grants for pre-commercial academic research, fostering innovation in the oncology ecosystem.
Yosemite adds value to its portfolio companies through a unique blend of venture capital and philanthropic support, enabling high-risk academic research to transition into viable commercial products. The firm leverages its network and expertise in oncology to enhance the development and market readiness of its investments.
Yosemite focuses on early-stage investments in oncology, specifically in cancer therapeutics, diagnostics, and care delivery. The firm looks for companies that are innovating in these areas and are at the seed or Series A funding stages.
Founders can reach out to Yosemite via email at info@yosemite.co. Specific details about the pitch process are not publicly disclosed, so it is advisable to provide a clear and concise overview of your startup and its alignment with Yosemite's focus on oncology.
Yosemite uniquely combines venture capital with academic philanthropy, providing grants to support early cancer research while also investing in companies that translate scientific discoveries into market-ready solutions. This dual approach allows the firm to nurture early-stage research and facilitate the development of effective therapies.
The firm operates globally, with a primary focus on the United States and the oncology ecosystem worldwide. This broad geographic scope allows Yosemite to partner with leading researchers and entrepreneurs across various regions.
While specific check sizes are not disclosed, Yosemite's focus on early-stage investments suggests that it is prepared to engage with startups at various funding stages, including seed and Series A rounds.
Yosemite adds value to its portfolio companies by combining financial support with strategic guidance, leveraging its network in the oncology ecosystem. The firm aims to facilitate the translation of scientific discoveries into effective therapies and improve patient experiences.
Superscout Pro
Is this page right?Reviewed · How the research works